#
Latest news with #DaiichiSankyoCo
Bloomberg
31-01-2025
- Business
- Bloomberg
AstraZeneca, Daiichi's Breast Cancer Drug Gets EU Backing
AstraZeneca Plc and Daiichi Sankyo Co. 's Datroway breast cancer treatment, which the companies expect will eventually become a blockbuster, was recommended for approval in the European Union. The green light from the European Medicines Agency is the first backing in the EU for the medicine, following its approval in the US and Japan.
Bloomberg
27-01-2025
- Business
- Bloomberg
AstraZeneca, Daiichi's Drug Wins Wider Use in Breast Cancer Patients
AstraZeneca Plc and Daiichi Sankyo Co. 's drug was cleared by US regulators for broader use in late-state breast cancer patients. The Food and Drug Administration approved Enhertu to be used among metastatic, hormone-positive breast cancer patients with a small number of HER2 receptors, the companies said in a statement Tuesday.
